We are live on ! Find out more
SBSB

Sullivan, Bruyette, Speros & Blaney Portfolio holdings

AUM $2.27B
1-Year Est. Return 50.71%
This Fund
S&P 500
This Quarter Est. Return
+13.17%
1 Year Est. Return
+50.71%
3 Year Est. Return
+46.71%
5 Year Est. Return
+87.02%
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$341M
Cap. Flow
+$104M
Cap. Flow %
4.86%
Top 10 Hldgs %
71.65%
Holding
406
New
52
Increased
172
Reduced
88
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 5.02%
2 Healthcare 2.02%
3 Financials 1.33%
4 Consumer Discretionary 1.25%
5 Industrials 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJT icon
201
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
$349K 0.02%
3,057
-1
-0% -$102
SPLK
202
DELISTED
Splunk Inc
SPLK
$349K 0.02%
2,054
+50
+2% +$9.56K
EW icon
203
Edwards Lifesciences
EW
$49.6B
$348K 0.02%
3,815
+794
+26% +$65.9K
PRU icon
204
Prudential Financial
PRU
$42.4B
$348K 0.02%
4,461
-129
-3% -$9.32K
BHC icon
205
Bausch Health
BHC
$2.58B
$343K 0.02%
16,500
BKNG icon
206
Booking.com
BKNG
$149B
$343K 0.02%
3,850
+475
+14% +$36.7K
PCAR icon
207
PACCAR
PCAR
$69.8B
$336K 0.02%
+5,840
New +$343K
BSCN
208
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$336K 0.02%
15,328
IEF icon
209
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$333K 0.02%
2,778
+1,956
+238% +$235K
TJX icon
210
TJX Companies
TJX
$174B
$333K 0.02%
4,880
+1,010
+26% +$61.4K
GL icon
211
Globe Life
GL
$14.2B
$330K 0.02%
3,475
PRF icon
212
Invesco FTSE RAFI US 1000 ETF
PRF
$9.79B
$329K 0.02%
12,365
TEVA icon
213
Teva Pharmaceuticals
TEVA
$40.8B
$326K 0.02%
33,750
AMD icon
214
Advanced Micro Devices
AMD
$776B
$320K 0.02%
3,492
+700
+25% +$60.4K
CDNS icon
215
Cadence Design Systems
CDNS
$93.6B
$320K 0.02%
2,344
+922
+65% +$108K
JBL icon
216
Jabil
JBL
$33B
$319K 0.01%
7,500
SYK icon
217
Stryker
SYK
$125B
$319K 0.01%
1,300
-3
-0.2% -$680
BNY
218
Bank of New York Mellon
BNY
$106B
$318K 0.01%
7,499
+457
+6% +$17.5K
DAL icon
219
Delta Air Lines
DAL
$57.5B
$317K 0.01%
7,885
+101
+1% +$3.67K
VFH icon
220
Vanguard Financials ETF
VFH
$13.5B
$316K 0.01%
4,335
+2,100
+94% +$139K
GILD icon
221
Gilead Sciences
GILD
$162B
$315K 0.01%
5,411
+131
+2% +$7.91K
BSV icon
222
Vanguard Short-Term Bond ETF
BSV
$44.7B
$313K 0.01%
3,780
-970
-20% -$80.4K
EXAS
223
DELISTED
Exact Sciences
EXAS
$312K 0.01%
2,356
-494
-17% -$59.7K
UL icon
224
Unilever
UL
$137B
$311K 0.01%
+4,586
New +$311K
LNC icon
225
Lincoln National
LNC
$8.73B
$307K 0.01%
6,103

Similar funds

Sullivan, Bruyette, Speros & Blaney's Q4 2020 Portfolio in Review

As of Q4 2020, Sullivan, Bruyette, Speros & Blaney held 406 positions worth $2.14B, up 19% from $1.8B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Sullivan, Bruyette, Speros & Blaney deployed $104M of net new capital in Q4 2020, opening 52 new positions and adding to 172 existing holdings. Its largest new stake was McCormick & Company Non-Voting: 6,000 shares worth $574K.

By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.29M trimmed.

  • Sullivan, Bruyette, Speros & Blaney's largest Q4 2020 buy was McCormick & Company Non-Voting: 6,000 shares worth $574K.
  • Sullivan, Bruyette, Speros & Blaney added most to Invesco Ultra Short Duration ETF in Q4 2020, an estimated $61.7M increase.
  • Sullivan, Bruyette, Speros & Blaney's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.29M.
  • Sullivan, Bruyette, Speros & Blaney fully exited Invesco BulletShares 2020 Corporate Bond ETF in Q4 2020, selling an estimated $801K.
  • Sullivan, Bruyette, Speros & Blaney's ten largest holdings make up 72% of its $2.14B portfolio in Q4 2020.
  • Sullivan, Bruyette, Speros & Blaney opened 52 new positions and closed 8 in Q4 2020.
  • Sullivan, Bruyette, Speros & Blaney's portfolio value rose 19% quarter-over-quarter to $2.14B.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q4 2020, filed 12 Feb 2021.